Global HER2-Positive Breast Cancer Market is estimated to be US$ 12.3 billion by 2030 with a CAGR of 4.4% during the forecast period

Download Sample

Published Date: May 2023

The Global HER2-Positive Breast Cancer market accounted for US$ 8.0 billion in 2020 and is estimated to be US$ 12.3 billion by 2030 and is anticipated to register a CAGR of 4.4%. Treatment for HER2-positive breast cancer refers to a kind of breast cancer in which a test indicates the presence of the protein human epidermal growth factor receptor 2 (HER2), which regulates cancer cell proliferation. The presence of HER2 should be checked in anyone who has been diagnosed with breast cancer. Breast cancer recurrence and death have previously been connected to HER2-positive tumours. With the use of chemotherapy and targeted treatment against HER2, the prognosis of HER2-positive breast tumours has dramatically improved.

The report " Global HER2-Positive Breast Cancer Market, By Treatment Type (Targeted Therapy, Chemotherapy, Endocrine Therapy, Immunotherapy and Others), By Route of Administration (Parenteral, Oral and Others), By Application (Hospital, Biotechnology & Pharmaceuticals company, Specialty Clinics, Research & Academic Institution and Others), By Distribution Channel ( Hospital pharmacy, Retail pharmacy and Online pharmacy) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

Key Highlights:

Biosimilars of trastuzumab are now being evaluated by the European Medicines Agency (EMA) and the Food and Drug Administration (FDA), with the first copy being submitted for approval in Japan in April 2017.
Phesgo—a combination of pertuzumab, trastuzumab, and hyaluronidase–zzxf—is approved by the US FDA for injection under the skin to treat adult patients with HER2-positive breast cancer that has progressed to other regions of the body, as well as adult patients with early HER2-positive breast cancer.

Analyst View:

Emerging markets and major investment in research and development are driving this industry's growth. The rise in HER2-positive breast cancer cases around the world has affected demand for novel HER2-positive breast cancer therapy drugs, which has propelled the HER2-positive breast cancer treatment market's growth. Furthermore, high immunotherapy acceptance and favourable reimbursement are viewed as optimistic indicators for HER2-positive breast cancer treatment. High treatment costs and the discontinuation of late-stage clinical trials are suspected to be limiting the market for HER2-positive breast cancer treatment.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global HER2-Positive Breast Cancer Market, By Treatment Type (Targeted Therapy, Chemotherapy, Endocrine Therapy, Immunotherapy and Others), By Route of Administration (Parenteral, Oral and Others), By Application (Hospital, Biotechnology & Pharmaceuticals company, Specialty Clinics, Research & Academic Institution and Others), By Distribution Channel ( Hospital pharmacy, Retail pharmacy and Online pharmacy) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

Key Market Insights from the report:

The Global HER2-Positive Breast Cancer Market accounted for US$ XX million in 2020 and is estimated to be US$ XX million by 2030 and is anticipated to register a CAGR of XX%. The Global HER2-Positive Market is segmented based on the treatment type, route of administration, application, distribution channel, and region.

By Treatment type, the Global HER2-PositiveBreast Cancer Market is segmented into Targeted Therapy, Chemotherapy, Endocrine Therapy, Immunotherapy and Others.
By Route of Administration, the market is segmented in Parenteral, Oral and Others.
By Application, the Global HER2-PositiveBreast Cancer Market is segmented into Hospital, Biotechnology & Pharmaceuticals company, Specialty Clinics, Research & Academic Institution and Others.
By Distribution channel, the market is segmented into Hospital pharmacy, Retail pharmacy and Online pharmacy.
By Region, the Global HER2-PositiveBreast Cancer Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America will hold the largest market share for HER2-positive breast cancer therapy.

Competitive Landscape:

The key players operating in the Global HER2-Positive Breast Cancer market includes Pfizer Inc., Eli Lilly and Company, Immunomedics, AstraZeneca, F. Hoffmann-La Roche Ltd, Radius pharmaceuticals, Merck & Co., Inc, Bayer AG, GlaxoSmithKline plc, Syndax pharmaceuticals, Takeda Pharmaceutical Company Limited, Novartis AG, Teva Pharmaceuticals Industries Ltd, Baxter, Mylan N.V., and Fresenius Kabi AG among others.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning.
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period.